Glucotrack (Nasdaq:GCTK) announced that it expects FDA investigational device exemption for its long-term CBGM later this year.

JointMedica, a global leader in orthopedic innovation, announces the commencement of an Investigational Device Exemption (IDE) study for its Polymotion® Hip Resurfacing (PHR®) device. The IDE study ...

The intravascular lithotripsy market has undergone high growth trailblazed by J&J subsidiary Shockwave Medical.

Full REMAIN-1 pivotal study enrollment anticipated in summer 2025 ...

Transformational 2024: successfully advanced from preclinical to clinical stage companyStrengthened leadership team to drive growth and advance ...

In 2024, ONWARD added 20 patents to its IP portfolio. It now has more than 150 issued patents, excluding EP country ...

To accelerate potential completion of ongoing partnership restructuring negotiations, Orchestra BioMed and Terumo have elected to enter a mediation process and are currently working on a procedural ...

Abbott Laboratories ABT recently unveiled favorable TRILUMINATE Pivotal trial data at the American College of Cardiology's Annual Scientific Session (ACC.25), held in Chicago. The data demonstrated ...

“Investors can gain exposure to the healthcare sector by owning the S&P 500 through a passively managed index fund or ETF.

A federal judge in Texas has blocked the FDA’s plans to bring laboratory-developed tests under the same regulations it uses ...

What do the upcoming trends in medical devices look like? In the fast-changing healthcare sector, keeping up-to-date with the newest developments in medical technology is crucial for experts and ...